Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
This Quarter Return
+16.76%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$29.3B
AUM Growth
+$29.3B
(+9.4%)
Cap. Flow
-$565M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
34.45%
Holding
1,250
New
131
Increased
368
Reduced
516
Closed
126
Top Buys
| 1 |
NetApp
NTAP
|
$174M |
| 2 |
Amazon
AMZN
|
$159M |
| 3 |
Netflix
NFLX
|
$134M |
| 4 |
Citigroup
C
|
$121M |
| 5 |
Eaton
ETN
|
$99.5M |
Top Sells
| 1 |
Amgen
AMGN
|
$260M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$150M |
| 3 |
Tesla
TSLA
|
$141M |
| 4 |
Visa
V
|
$114M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$107M |
Sector Composition
| 1 | Technology | 33.23% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 13.46% |
| 4 | Industrials | 11.6% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
American Express
AXP
$227B
| $128M | 0.44% |
560,539
+367,278
| +190% | +$83.6M |
|
52
Cisco
CSCO
$267B
| $123M | 0.42% |
2,461,184
-1,929,101
| -44% | -$96.3M |
|
53
Exxon Mobil
XOM
$480B
| $121M | 0.41% |
1,039,733
-495,998
| -32% | -$57.7M |
|
54
Apollo Global Management
APO
$75.9B
| $118M | 0.4% |
1,045,422
+552,893
| +112% | +$62.2M |
|
55
Emcor
EME
$27.9B
| $117M | 0.4% |
333,718
-25,096
| -7% | -$8.79M |
|
56
Johnson & Johnson
JNJ
$427B
| $116M | 0.4% |
734,377
+20,054
| +3% | +$3.17M |
|
57
Burlington
BURL
$18.5B
| $115M | 0.39% |
493,614
+406,426
| +466% | +$94.4M |
|
58
Cintas
CTAS
$82.5B
| $113M | 0.39% |
164,089
+18,133
| +12% | +$12.5M |
|
59
Merck
MRK
$211B
| $112M | 0.38% |
848,781
+472,479
| +126% | +$62.3M |
|
60
Manhattan Associates
MANH
$12.6B
| $107M | 0.37% |
427,326
+43,704
| +11% | +$10.9M |
|
61
Medpace
MEDP
$13.4B
| $105M | 0.36% |
260,445
+6,320
| +2% | +$2.55M |
|
62
Gilead Sciences
GILD
$140B
| $104M | 0.35% |
1,417,354
-19,677
| -1% | -$1.44M |
|
63
D.R. Horton
DHI
$51.5B
| $103M | 0.35% |
625,629
-131,793
| -17% | -$21.7M |
|
64
W.R. Berkley
WRB
$27.3B
| $102M | 0.35% |
1,157,290
+5,407
| +0.5% | +$478K |
|
65
Goldman Sachs
GS
$221B
| $101M | 0.35% |
242,999
+205,709
| +552% | +$85.9M |
|
66
ResMed
RMD
$39.1B
| $98.8M | 0.34% |
499,031
+485,540
| +3,599% | +$96.2M |
|
67
Bristol-Myers Squibb
BMY
$96.6B
| $98.2M | 0.34% |
1,811,285
-101,964
| -5% | -$5.53M |
|
68
Xylem
XYL
$34.1B
| $97.8M | 0.33% |
757,071
-133,023
| -15% | -$17.2M |
|
69
PepsiCo
PEP
$203B
| $96.9M | 0.33% |
553,911
-241,980
| -30% | -$42.3M |
|
70
Nike
NKE
$110B
| $96.3M | 0.33% |
1,024,429
-43,180
| -4% | -$4.06M |
|
71
Procter & Gamble
PG
$368B
| $95.1M | 0.32% |
586,309
-42,520
| -7% | -$6.9M |
|
72
AutoZone
AZO
$69.8B
| $93.1M | 0.32% |
29,538
+14,558
| +97% | +$45.9M |
|
73
Carrier Global
CARR
$52.8B
| $92.2M | 0.31% |
1,586,408
+609,071
| +62% | +$35.4M |
|
74
Lam Research
LRCX
$123B
| $92.1M | 0.31% |
94,845
+1,909
| +2% | +$1.85M |
|
75
Molina Healthcare
MOH
$9.61B
| $92M | 0.31% |
223,825
+91,813
| +70% | +$37.7M |
|